Y-mAbs Therapeutics, Inc.

NASDAQ:YMAB

4.91 (USD) • At close March 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016
Assets:
Current Assets:
Cash & Cash Equivalents 67.23478.637105.762181.564114.634207.136147.8490.48316.875
Short Term Investments 000000000
Cash and Short Term Investments 67.23478.637105.762181.564114.634207.136147.8490.48316.875
Net Receivables 19.68822.45412.5317.71200000
Inventory 7.2145.0656.7025.512-0.80000
Other Current Assets 4.3734.9555.4527.4737.7294.8193.6920.8720.386
Total Current Assets 98.509111.111130.447202.261122.363211.955151.53291.35517.261
Non-Current Assets:
Property, Plant & Equipment, Net 0.8591.6362.3435.6896.3944.0410.20500
Goodwill 000000000
Intangible Assets 2.2762.6312.9861.66300000
Goodwill and Intangible Assets 2.2762.6312.9861.66300000
Long Term Investments 000000000
Tax Assets 000000000
Other Non-Current Assets 18.2612.4915.683.173.290.370.1870.7720
Total Non-Current Assets 21.39516.75811.00910.5229.6844.4110.3920.7720
Total Assets 119.904127.869141.456212.783132.047216.366151.92492.12717.261
Liabilities & Equity:
Current Liabilities:
Account Payables 6.6626.0614.17513.5529.3728.525.8725.9092.227
Short Term Debt 0.630.9021.7363.5663.9321.032000
Tax Payables 000000000
Deferred Revenue 000000000
Other Current Liabilities 16.40613.16612.37310.7576.2314.0343.2512.0160.748
Total Current Liabilities 23.69820.12828.28427.87519.53513.5869.1237.9252.975
Non-Current Liabilities:
Long Term Debt 0.190.5170.8991.8512.0131.714000
Deferred Revenue Non-Current 000000000
Deferred Tax Liabilities Non-Current 000000000
Other Non-Current Liabilities 4.0126.2393.0522.9514.6632.1632.2742.052.225
Total Non-Current Liabilities 4.2026.7563.9514.8026.6763.8772.2742.052.225
Total Liabilities 27.926.88432.23532.67726.21117.46311.3979.9755.2
Equity:
Preferred Stock 000000000
Common Stock 0.0040.0040.0040.0040.0040.0040.0030.0030.002
Retained Earnings -487.136-457.47-436.043-340.475-285.2-165.863-84.835-41.561-22.4
Accumulated Other Comprehensive Income/Loss 2.2640.4491.3311.371-0.5260.050.007-0.1690.03
Other Total Stockholders Equity 576.872558.002543.929519.206391.558364.712225.352123.87934.429
Total Shareholders Equity 92.004100.985109.221180.106105.836198.903140.52782.15212.061
Total Equity 92.004100.985109.221180.106105.836198.903140.52782.15212.061
Total Liabilities & Shareholders Equity 119.904127.869141.456212.783132.047216.366151.92492.12717.261